Filtros de búsqueda

Lista de obras de Adriano Venditti

'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study

artículo científico publicado en 2019

A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia.

artículo científico publicado en 2015

A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.

artículo científico publicado en 2016

A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, As

artículo científico publicado en 2012

A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype

artículo científico publicado en 1997

A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias

artículo científico publicado en 2010

A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0).

artículo científico publicado en 2000

Acute megakaryoblastic leukemia: experience of GIMEMA trials

artículo científico publicado en 2002

Advances in the treatment of elderly and frail patients with acute myeloid leukemia.

artículo científico publicado en 2014

All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemias

scientific article published on 01 February 1993

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.

artículo científico

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

artículo científico publicado en 2002

An allele-specific rt-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia.

artículo científico publicado en 2008

An evaluation of enasidenib for the treatment of acute myeloid leukemia

artículo científico publicado en 2019

Automated haematology analysers in acute and chronic leukaemias

scientific article published on 01 January 1998

Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program

artículo científico publicado en 2010

Azacitidine for the treatment of patients with acute myeloid leukemia: report of 82 patients enrolled in an Italian Compassionate Program

scientific article published on 14 July 2011

Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management

artículo científico publicado en 2019

CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.

artículo científico publicado en 2011

CD7 expression in acute myeloid leukemia

artículo científico publicado en 1995

CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias

artículo científico publicado en 2004

Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.

artículo científico publicado en 2014

Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells

artículo científico publicado en 2020

Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients

scientific article published on 01 August 2004

Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia

scientific article published on 01 April 2002

Clinical significance of CD38 expression in chronic lymphocytic leukemia

artículo científico publicado en 2001

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2006

Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia

artículo científico publicado en 2015

Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the campus all network

artículo científico publicado en 2019

Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data

artículo científico publicado en 2014

Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia

artículo científico publicado en 2018

Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients

scientific article published on 01 January 2003

Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making

artículo científico publicado en 2013

Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies

scientific article published on 28 November 2019

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2008

Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia

artículo científico publicado el 1 de julio de 1995

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

artículo científico publicado en 2010

Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials

artículo científico publicado en 2018

Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm.

artículo científico publicado en 2008

Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

artículo científico publicado en 2015

Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.

artículo científico publicado en 2008

Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia

scientific article published on 16 January 2019

Emerging strategies for the treatment of older patients with acute myeloid leukemia.

artículo científico publicado en 2016

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage

artículo científico publicado en 2015

Epstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2009

Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes

scientific article published on 17 November 2007

Extensive toxic epidermal necrolysis following brentuximab vedotin administration

article

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

artículo científico publicado en 2017

Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group

artículo científico publicado en 2000

First report of t(8;21)(q22;q22) in a case of de novo acute monoblastic leukemia.

artículo científico publicado en 1995

Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23+/MLL+ translocation in leukaemia

scientific article published on 01 June 2003

Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party

artículo científico publicado en 2011

Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy

artículo científico publicado en 2005

GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors

artículo científico publicado en 2011

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

artículo científico publicado en 2019

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

artículo científico publicado en 2016

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia

artículo científico publicado en 2004

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

artículo científico publicado en 2007

Health technology assessment-based approach to flow cytometric immunophenotyping of acute leukemias: a literature classification

artículo científico publicado en 2020

Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party.

artículo científico publicado en 2008

High interleukin-6 plasma levels in acute promyelocytic leukemia

scientific article published on 01 June 1992

High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma

artículo científico publicado en 2014

High-dose chemotherapy in adult acute myeloid leukemia: rationale and results.

artículo científico publicado en 1996

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial

artículo científico publicado en 2013

Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin.

artículo científico publicado en 2013

Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management

artículo científico publicado en 2008

Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype

scientific article published on 06 December 2018

In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab

scientific article published on 12 October 2019

Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia

artículo científico publicado en 1993

Increased levels of circulating interleukin-6 in patients with newly diagnosed non-Hodgkin's lymphomas

scientific article published on 01 June 1994

Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia

artículo científico publicado en 2013

Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors

artículo científico publicado en 1996

Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia

artículo científico publicado en 2014

Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome

scientific article published on 21 February 2018

Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study

artículo científico publicado en 2017

Leukocyte alkaline phosphatase score in plasma cell dyscrasias: correlation with disease severity and circulating levels of granulocyte-colony stimulating factor

artículo científico publicado en 1995

Longitudinal detection of DNMT3AR882H transcripts in patients with acute myeloid leukemia.

artículo científico publicado en 2018

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the

artículo científico publicado en 2016

M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience

artículo científico publicado en 2008

MRD in AML: The Role of New Techniques

scientific article published on 23 July 2019

Mini-extracorporeal circulation minimizes coagulation abnormalities and ameliorates pulmonary outcome in coronary artery bypass grafting surgery

scientific article published on 14 February 2013

Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia

artículo científico publicado en 2018

Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia

artículo científico publicado en 2014

Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients

artículo científico publicado en 2015

Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party.

artículo científico publicado en 2018

Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosis.

artículo científico publicado en 1996

Monitoring of minimal residual disease in acute myeloid leukemia

artículo científico publicado en 2009

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow

scientific article published on 01 May 2007

Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

artículo científico publicado en 2003

Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse

scientific article published on 23 July 2019

New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophilia

artículo científico publicado en 2001

Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paper

scientific article published on 10 March 2020

Novel Agents for Acute Myeloid Leukemia

artículo científico publicado en 2018

Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia

artículo científico publicado en 2007

O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro.

artículo científico publicado en 2006

P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.

artículo científico publicado en 2003

P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.

artículo científico publicado en 1999

Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors

scientific article published on 01 April 2002

Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation

artículo científico publicado en 2004

Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).

artículo científico publicado en 2015

Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia.

artículo científico publicado en 2016

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

artículo científico publicado en 2003

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients

artículo científico publicado en 2011

Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis

scientific article published on 01 May 2010

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and [...]

artículo científico publicado en 2010

Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

artículo científico publicado en 2016

Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study.

artículo científico publicado en 1995

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

artículo científico publicado en 2013

Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry

artículo científico publicado en 2015

Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.

artículo científico publicado en 2014

Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.

artículo científico publicado en 2016

Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia

artículo científico publicado en 2018

Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera

artículo científico publicado en 1998

Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).

artículo científico publicado en 2013

Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia

scientific article published on 01 September 2006

Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?

artículo científico publicado en 2020

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

artículo científico publicado en 2010

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

artículo científico publicado en 2015

Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)

artículo científico publicado en 2011

The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia

artículo científico publicado en 2005

The emerging role of measurable residual disease detection in AML in morphologic remission

artículo científico publicado en 2018

The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.

artículo científico publicado en 2010

The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia

artículo científico publicado en 2006

Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness

scientific article published on 02 January 2020

Thoracic cord compression caused by epidural extramedullary hematopoiesis during erythroid-stimulating agent therapy in two patients with myelodysplastic syndromes

artículo científico publicado en 2013

Thrombosis in adult patients with acute leukemia.

artículo científico

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

artículo científico publicado en 2008

Treatment of Low-Blast Count AML using Hypomethylating Agents

artículo científico publicado en 2017

Trisomy 4 as the sole karyotypic anomaly in acute biphenotypic leukemia with B lineage markers and in acute minimally differentiated myeloid leukemia (M0)

scientific article published on 01 March 1995

Two Novel Methods for Rapid Detection and Quantification of DNMT3A R882 Mutations in Acute Myeloid Leukemia

artículo científico publicado en 2014

Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies

scientific article published on 07 August 2019

Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?

artículo científico publicado en 2017